The Mondor Institute for Biomedical Research (IMRB, U955 Inserm – Université Paris Est Créteil, UPEC) is one of the main biomedical research centres in the eastern part of the Paris region with national and international influence. The research teams develop high-level translational research in a wide variety of fields in direct connection with healthcare services and a large number of patient cohorts.

The IMRB was created in 2009 and recently evaluated successfully as part of the latest HCERES E wave. It has been re-established by Inserm and UPEC for a period of five years starting on January 1, 2026. It comprises more than 600 people belonging to 17 research teams, a General Secretariat responsible for managing the Institute, and logistical support for the teams and technology platforms.

The research teams are structured around three areas:

The management of the IMRB is supported by a Directorial committee and a Center committee composed of team leaders and elected members from each category of staff: Researchers & Teacher-Researchers, Research Support Staff and Doctoral & Post-Doctoral Students (Figure ppt).

A Scientific Integrity cell assists the Director in his field of competence. A Grant office provides support to researchers for the detection of Calls for Proposals and for their applications.

Working groups (WGs) from the general assemblies of the staff and led by their representatives are in charge of the different aspects of the life of the IMRB: scientific animation, international relations, strategy, follow-up of young researchers, etc.

The scientific output of the IMRB over the last 5 years amounts to nearly 3500 original articles and letters and 40 patents. In the field of education and in the same period, the IMRB has produced 110 university theses. The IMRB teams are involved in several European projects and report 150 international collaborations with laboratories all over the world, mainly European and American.

12 000m²

de laboratories

150

International collaborations

10

European projects

3500+

articles in 5 years

40

Patents

10

Start-ups